Acutaas Chemicals informs about outcome of board meeting

17 Oct 2025 Evaluate

In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Acutaas Chemicals has informed that the Board of Directors of the Company at their meeting held on Friday, October 17, 2025, considered & approved the Unaudited Standalone & Consolidated Financial Results for the second quarter & half year ended on September 30, 2025 along with Balance Sheet and Cash Flow Statement for the half year ended September 30, 2025, as reviewed and recommended by the Audit Committee, and the Limited Review Report issued by Statutory Auditors of the Company, Maheshwari & Co., Chartered Accountants. The Board Meeting commenced at 11.00 am and concluded at 11.50 am.

The above information is a part of company’s filings submitted to BSE.  

Acutaas Chemicals Share Price

1696.65 -13.20 (-0.77%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×